Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Pharmacy Practice, MSc, Slides of Pharmacy

The programme aims to enable pharmacists to develop post graduate skills to gain „general level‟ pharmacist practitioner status.

Typology: Slides

2021/2022

Uploaded on 09/27/2022

jeena
jeena 🇬🇧

4.2

(6)

215 documents

1 / 16

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Programme approval 2009/10
1
PAF originally approved: 19 January 2011
PAF modified re: programme table: 17 February 2012
PAF finalised for 2012/13: 22 October 2012
PROGRAMME APPROVAL FORM
SECTION 1 THE PROGRAMME SPECIFICATION
1. Programme title and designation
Pharmacy practice
For undergraduate programmes only
Single honours Joint Major/minor
2. Final award
Award
Title
Credit
value
ECTS
equivalent
Any special criteria
MSc
Pharmacy Practice
180
90
N/A
MSc
Pharmacy Practice
(Prescribing)
180
90
Completion of the Practice Certificate
in Independent Prescribing
(7BBPM022) and any 15 credit
modules and the Pharmacy Practice
Dissertation Module.
3. Nested award
Award
Title
Credit
value
ECTS
equivalent
Any special criteria
PGCert
In Independent
Prescribing
60
30
To include completion of Practice
Certificate in Independent Practice
module (7BBPM022)
PGCert
In Pharmacy Practice
60
30
To include completion of any four 15
credit modules
PGDip
In Pharmacy Practice
(Prescribing)
120
60
To include completion of the Practice
Certificate in Independent Practice
module (7BBPM022) and any four 15
credit modules
PGDip
In Pharmacy Practice
120
60
To include the completion of any
eight 15 credit modules
4. Exit award
Award
Title
Credit
value
ECTS
equivalent
Any special criteria
See above
5. Level in the qualifications framework
M
6. Attendance
Part-time
Distance
learning
Mode of attendance
Yes
No
Minimum length of programme
n/a
PGCert
8 months
PGDip
16 months
MSc
24 months
Maximum length of programme
n/a
PGCert
3 years
PGDip
4 years
MSc
6 years
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff

Partial preview of the text

Download Pharmacy Practice, MSc and more Slides Pharmacy in PDF only on Docsity!

1 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

PROGRAMME APPROVAL FORM

SECTION 1 – THE PROGRAMME SPECIFICATION

1. Programme title and designation Pharmacy practice

For undergraduate programmes only Single honours Joint Major/minor

2. Final award

Award Title Credit value

ECTS

equivalent

Any special criteria

MSc Pharmacy Practice 180 90 N/A

MSc Pharmacy Practice (Prescribing)

180 90 Completion of the Practice Certificate in Independent Prescribing (7BBPM022) and any 15 credit modules and the Pharmacy Practice Dissertation Module.

3. Nested award

Award Title Credit value

ECTS

equivalent

Any special criteria

PGCert In Independent Prescribing

60 30 To include completion of Practice Certificate in Independent Practice module (7BBPM022)

PGCert In Pharmacy Practice 60 30 To include completion of any four 15 credit modules

PGDip In Pharmacy Practice (Prescribing)

120 60 To include completion of the Practice Certificate in Independent Practice module (7BBPM022) and any four 15 credit modules

PGDip In Pharmacy Practice 120 60 To include the completion of any eight 15 credit modules

4. Exit award

Award Title Credit value

ECTS

equivalent

Any special criteria

See above

5. Level in the qualifications framework M 6. Attendance

Full-time Part-time Distance learning Mode of attendance No Yes No Minimum length of programme

n/a n/a

PGCert 8 months

PGDip 16 months

MSc 24 months

Maximum length of programme

n/a n/a

PGCert 3 years

PGDip 4 years

MSc 6 years

2 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

7. Awarding institution/body King‟s College London 8. Teaching institution King‟s College London 9. Proposing department Department of Pharmacy 10. Programme organiser and contact details

Dr. Sue C. Jones Department of Pharmacy Franklin-Wilkins Building Waterloo Campus Room 5.82, Extn. 4847 sue.jones@kcl.ac.uk

11. UCAS code (if appropriate) n/a 12. Relevant QAA subject benchmark/ professional and statutory body guidelines

n/a

13. Date of production of specification February^2010 14. Date of programme review March 2016

15 Educational aims of the programme i.e. what is the purpose if the programme and general statements about the learning that takes place over the duration of the programme

The programme aims to enable pharmacists to develop post graduate skills to gain „general level‟ pharmacist practitioner status. The purpose of the programme is to enable pharmacists to effectively develop and deliver modern patient centred pharmaceutical services within the primary care. Pharmacists will learn:  to develop and demonstrate a reflective conceptual understanding of the issues and roles associated with complex clinical decision making  an in-depth understanding across a broad range of the subjects relative to the professional roles and responsibilities of a pharmacist and contribute actively to the planning and delivery of patient focussed care in the National Health Service  the knowledge, skills, competencies and proficiencies to meet the new regulations requirements for on-going revalidation by the General Pharmaceutical Council to provide safe and effective pharmacy services considered essential  the skills required to undertake a research project that includes the construction of research questions, critical exploration and critical evaluation of outcomes appropriate to the development of pharmaceutical care.

16. Educational objectives of the programme/programme outcomes (as relevant to the SEEC Credit Level Descriptors) By the end of the programme the graduate will be able:

  1. To critically discuss the organisation and structure of the National Health Service and to offer critical insight into the complexities and limitations associated with the delivery of pharmaceutical care across healthcare sectors in order to improve patient outcomes
  2. To critically discuss the application and limitations of evidence based practice in the care of patients with multiple complex pathologies drawing on evidence to inform pharmacy practice including the self care and self management agenda
  3. To design, conduct and critically evaluate autonomously and independently, an investigation into pharmaceutical care using appropriate methods which draw on relevant evidence from the literature

4 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

 Delivery of defined areas of practice as outlined in the local Primary Care Trust‟s published Pharmaceutical Needs Assessment and Joint Needs Assessment;  Workforce development;  Maximising the benefit of the community pharmacy contractual framework to support General Medical Practitioners‟ deliver their Quality and Outcomes Framework;  Research methods, techniques for research and academic enquiry.

 Practice assessment  Plan and record (CPD record)  Review of essential components of the community pharmacy contractual framework obligations including community pharmacy patient questionnaire, change management supported by practice audits and multi- disciplinary audits.  Oral Presentation  Written dissertation  Poster presentation  Research abstract

Skills and other attributes

Intellectual skills:

  1. To appraise and critically evaluate evidence based guidelines to inform patient care.
  2. To work as a member of the health and social care team to apply in a range of practice settings the knowledge and understanding required to meet patients‟ needs.
  3. To support the delivery of a range of integrated care pathways
  4. To critically evaluate patient care and to apply sociological concepts to the development and delivery of public health
  5. To analyse and implement policy to inform care in a range of settings
  6. To critically review, analyse, synthesise, summarise and present information in a manner that is understood by a range of audiences from patients and carers to healthcare professionals
  7. To analyse and interpret data and utilise knowledge and understanding of physiology and pathophysiology of a range of long term conditions in accord with a designated scope of practice.
  8. To construct an argument based on a range of different information sources.
  9. Demonstrate an advanced understanding of the legal, ethical and professional frameworks in relation to medicines use.
  10. To document in a manner that satisfies the legal, ethical and governance requirements of patient care.

These are achieved through the following teaching/learning methods and strategies :

Intellectual skills set out in points 1 – 10 are developed through workshops, role play scenarios, seminar and tutorial sessions, oral and poster presentations.

Assessment :

Skills are assessed using a variety of methods including:  Written examination  Multiple Choice Questions (MCQ)  Objective Structured Clinical Examination (OSCE)  Critical review of therapeutic area  Portfolio of Evidence to include performance assessment tools o CbD (Case based discussion) o MRCF (Medication Related Consultation Framework) o review of clinical interventions  Business proposal to support a pharmacy practice development  Therapeutic framework  Medicines related risk framework  Plan and record (CPD record)  Review of essential components of the community pharmacy contractual framework obligations including community pharmacy patient

5 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

questionnaire, change management supported by practice audits and multi- disciplinary audits.  Oral Presentation  Written dissertation  Poster presentation  Research abstract Student centred learning involving library based research, data retrieval and presentations will be encouraged to reinforce and enhance these skills.

Practical skills :

  1. To autonomously plan, design, conduct and critically analyse a programme of research.
  2. To prepare, deliver and monitor a care plan for individual patients within a defined scope of practice.
  3. To ensure that all prescribing processes comply with recent changes in legislation.
  4. To provide prescribing support to health and social care colleagues
  5. To apply in-depth knowledge from a variety of sources to deliver effective and safe patient care.
  6. To deliver oral presentations using in a range of clinical settings using a variety of methods.
  7. To acquire an in-depth understanding of a range of clinical conditions in line with local priorities and patients‟ needs.
  8. To select and apply a range of diagnostic tools to diagnose, monitor and critically review patients‟ treatment plans.
  9. To communicate risk benefit information to healthcare professionals and patients in order to inform the design of a therapeutic intervention.
  10. To produce a report that demonstrates an ability to extract, critique and summarise information from a range of different sources.

These are achieved through the following teaching/learning methods and strategies :

Subject practical skills are developed in a coordinated and progressive manner throughout the programme including workshop tutorials, computer-based sessions and in the work place when undertaking work-based evaluations. The skills associated with the development of research methods protocols are met during the sustained research project.

Reflective practitioner skills are developed throughout the programme using blended learning, the combination of taught and self directed learning using a range of delivery methods. Students will develop their learning supported by peer learning and peer review.

Pharmacy practice will be informed by evidence and patient evaluation. This will provide a coherent approach to supporting the development of reflective „general level‟ pharmacist practitioner. Critical analysis skills will be developed throughout the programme informed by metrics, audit, peer review and patient evaluation.

Assessment : A variety of assessment methods are used to assess skills, these may include:  Written examination  Multiple Choice Questions (MCQ)  Objective Structured Clinical Examination (OSCE)  Critical review of therapeutic area  Portfolio of Evidence to include performance assessment tools o CbD (Case based discussion) o MRCF (Medication Related Consultation Framework)

7 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

questionnaire, change management supported by practice audits and multi- disciplinary audits.  Oral Presentation  Written dissertation  Poster presentation  Research abstract

17. Statement of how the programme has been informed by the relevant subject benchmark statement(s)/professional and statutory body guidelines

The proposed programme structure will include the accredited Post-graduate Practice Certificate in Independent Prescribing (this has been approved by the Royal Pharmaceutical Society of Great Britain) and the commissioned module Oral Contraception Services module (this meets the clinical and corporate governance standards of Southwark Primary Care Trust and acts as the formal accreditation process for the enhanced service offered by community pharmacists within the community pharmacy contractual framework). There are no specific benchmark statements for this programme; however, attention has been placed upon the QAA benchmarking statements for pharmacy so that the programme and curriculum are informed by the specific subject knowledge, abilities and skills outlined in these statements and build on for postgraduate level. The programme has been developed informed by collaboration between Higher Education Intuitions in the South East of England supported by the Joint Programme Board, and incorporates changes and development requirements contained within the community pharmacy contractual framework and health policies. The programme will support the General Pharmaceutical Council standards underpinning the re-validation process.

18. In cases of joint honours programmes please provide a rationale for the particular subject combination, either educational or academic

n/a

Which is the lead department and/or school?

8 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

1 9. Programme structure

Please complete the following table and, if appropriate to include joint, major/minor or other variations

Code =code of each module available for the programme Title = title of each module available for the programme, plus its credit level and credit value Status = please indicate whether the unit/module is introductory (I), core (Cr), compulsory (Cp), one or more of however many modules must be passed to progress (CrCp), (P) professional (i.e. module testing skills/ competency that has no credit level or value but is a professional body requirement) or optional (O) for each type of programme. For postgraduate programmes use the “single honours” column Pre requisite/Co-requisite =where appropriate please indicate whether the module is pre-requisite to another module or co-requisite by noting pre or co and the module code that is pre/co-requisite to. Assessment = please indicate in broad terms the assessment for the module eg written examinations, coursework (Note: the availability of optional modules may vary slightly from year to year, the following are the modules available at the commencement of the programme)

Code Title Credit level

Credit value

Status (I, Cr, CP, CrCP, P, O) for each type of module

Pre-requisite/Co- requisite (please note the module code)

Assessment

Single Joint Major/ minor

Single Joint Major / minor Part-time Study (this is a two year cycle of modules) 7TTY (KLI module)

Personal development and continuing professional development

7 15 O Coursework: critical account

7BBPP

Establishing professional & clinical practice within a pharmacy context

7 15 O

1 )Therapeutic review of two patients linked to scope of practice 2 ) Critical reflection of personal development plan

7BBPP004 Supporting patients with mental illness

7 15 O

  1. Written report of therapeutic framework
  2. Critical reflection of three case summaries
  3. Oral presentation of MRCF in the context of mental illness

10 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

7BBPP013 Paediatric Pharmaceutical Care

7 15 O

  1. coursework, portfolio
  2. clinical examination
  3. presentation of written case history
  4. review of element of service delivery with implement plan

7BBPP008 Service development in a pharmacy context

7 15 O

  1. .Development of a business plan 2.Critical reflection of business plan 3.Presentation of business plan

7BBPP005 Medicines and older people 7 15 O

1.Critical reflection of risk framework of a complex patient 2.Reflection of case summaries of clinical contributions for two complex patients

  1. Oral presentation
  2. Portfolio

7TTY (KLI module)

Professional development in the workplace

7 15 O

work based assignment or equivalent

7BBPP

Delivering effective, patient-centred care in a pharmacy context

7 15 O

1.Design an informed adherence strategy to facilitate patient centred care 2.Demonstrate the application of the adherence strategy using a consultation framework 3.Oral presentation

  1. Portfolio

7BBPP

Supporting self management of cardiovascular disease

7 15 O

  1. Written report of therapeutic framework
  2. Critical reflection of case summaries
  3. Oral presentation of structured consultation framework
  4. Observed structured clinical examination
  5. Portfolio

11 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

7BBPP

Supporting self management of respiratory disease

7 15 O

  1. Written report of therapeutic framework
  2. Critical reflection of two case summaries
  3. Oral presentation of case study
  4. OSCE
  5. Portfolio

7BBPP 024

Supporting Self- Management of Contraception and Sexual Health

7 15 O

  1. Written report of therapeutic framework
  2. Critical reflection of two case summaries
  3. Oral presentation of case study
  4. OSCE
  5. Portfolio

7BBPP011 Research Methods 7 15 O

Pharm acy practic e dissert ation

  1. Research Proposal, 2.Critical reflection of proposal presentation

7TTY

(KLI

Module)

Fundamentals of Pedagogy 7 15 O Coursework

7TTY

(KLI

Module)

Management People in the Work Environment 7 15 O^ Coursework

7TTY (KLI Module)

Interprofessional Leadership and Learning 7 15 O^ Coursework

7TTY0 012 (KLI Module)

Models of Expertise 7 15 O Coursework

7TTY (KLI Module)

e-Pedagogy 7 15 O Coursework

13 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

Other relevant information to explain the programme structure Please note that new students enrolling on the information provided on this section of the PAF will have these regulations stipulated throughout their programme of study. The only exception to this will be if there are changes made by Professional regulatory or Statutory Bodies that are notes to this programme.

Students who undertake the programme as full-time are expected to undertake the dissertation during the second year of their studies

14 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

20. Marking criteria Pass marks and conditions for progression are as specified in the Academic Regulations for Taught Postgraduate Students established by King‟s College, London. 21. Will this Programme Board of Examiners report to an existing Board, and if so which one? If a new Programme Board of Examiners is to be set up please note name of Board here This programme has a board of examiners and will report to the Postgraduate Pharmacy Practice Exam Board. A board currently exists for the Practice Certificate in independent prescribing. 22. Please confirm that the process for nominating External Examiners has commenced, and if known, note whom the nominated External Examiner(s) may be

The external examiner will be Dr. Karen Hodson (Cardiff) And the intercollegiate examiner may be Professor Felicity Smith ((School of Pharmacy)

23. Particular features of the programme which help to reduce the barriers experienced by disabled students to ensure that the programme is accessible to all students who meet the entry requirements Admissions All students in receipt of an offer receive an information booklet on the support services offered by the College. All students receiving offers who have indicated they have a disability in their application receive a letter from the School Disability Adviser with her contact details and offering the applicant the opportunity to discuss their requirements.

Publicity and Module Booklets These clearly communicate the key skills that will be required during the programme, the content of each module, the intended teaching methods to be used and module status (core/compulsory/optional).

Teaching Methods A wide range of teaching methods is utilised (as demonstrated by box 17).

Assessment Advice has been taken from the Equality & Diversity Department to ensure assessment methods do not unfairly discriminate against students with disabilities. The College‟s Special Examination Assessment Committee (SEAC) considers requests for adjustments to assessment to take account of learning and/or physical disabilities. Module outlines specify the assessment methods that will be used and explain that SEAC will need to be notified about requests for alternative assessment methods. The form that the alternative assessment will take has been specified for each module in advance.

Feedback Feedback on the programme will be regularly collected from students about their learning experience. The information collected is used towards the on-going development and improvement of the programme.

16 PAF originally approved: 19 January 2011 PAF modified re: programme table: 17 February 2012

Nature of the involvement of external body

Description of the learning resources available at the off- campus location Oral hormonal contraception services: Clinical assessment portfolio (see document for further details). Doctor or nurse mentor with appropriate qualifications (for details see section 14 prerequisites). Clinical environment of providing access to clients requiring oral hormonal contraception services (see details on clinical environments above).

What mechanisms will be put in place to ensure the ongoing monitoring of the delivery of the module Oral hormonal contraception services: Clinical placement details submitted and reviewed by the module organiser for appropriateness as part of the application process via the course specific application form Student self assessment audit of the clinical placement is included as an element within the clinical assessment portfolio and submitted for assessment. Referral to the course team is required if audit indicates learning environment is not appropriate. Mentor‟s details submitted and reviewed by the module organiser for appropriateness as part of the application process via the course specific application form.

Please attach report of the visit to the off-campus location

5. Recognition of study or award of credit thorough off-campus study or placement – Please indicate how the time will be spent, the length of time out, the amount of credit and whether it is a compulsory or optional part of the programme

N/A Year abroad Year in employment Placement Other (please specify)

Time spent ……………………Credit amount…….Compulsory/optional………………….

6. Please provide a rationale for any such time outside the College, other than that which is a requirement of a professional or statutory body

N/A

7. Please give details if the programme requires validation or accreditation by a professional or statutory body

Name and address of PSB

N/A

Frequency of validation/ accreditation Date of next validation/ accreditation